{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T07:16:16Z","timestamp":1763018176751},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,4,25]],"date-time":"2020-04-25T00:00:00Z","timestamp":1587772800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,4,25]],"date-time":"2020-04-25T00:00:00Z","timestamp":1587772800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Reprod Biol Endocrinol"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Assisted reproductive technology (ART) insurance mandates resulted in improved access to infertility treatments like intracytoplasmic sperm injection (ICSI). Our objective was to examine whether ART insurance mandates demonstrate an increased association with ICSI use.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>In this retrospective cohort study, clinic-specific data for 2000\u20132016 from the Centers for Disease Control (CDC) were grouped by state and subgrouped by the presence and extent of ART state insurance mandates. Mandated (<jats:italic>n<\/jats:italic>\u2009=\u20098) and non-mandated (<jats:italic>n<\/jats:italic>\u2009=\u200922) states were compared for ICSI use and male factor (MF) infertility in fresh non-donor ART cycles with a transfer in women &lt;\u200935\u2009years. Clinical pregnancy (CPR), live birth (LBR) rates, preimplantation genetic testing (PGT), elective single-embryo transfer (eSET) and twin birth rates per clinic were evaluated utilizing Welch\u2019s t-test. Pearson correlation was used to measure the strength of association between MF and ICSI; ICSI and CPR, and ICSI and LBR over time. Results were considered statistically significant at a <jats:italic>p<\/jats:italic>-value of &lt;\u20090.05, with Bonferroni correction used for multiple comparisons.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>From 2000 to 2016, ICSI use per clinic increased in both mandated and non-mandated states. ICSI use per clinic in non-mandated states was significantly greater from 2011 to 2016 (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05, all years) than in mandated states. Clinics in mandated states had less MF (30.5\u2009\u00b1\u200915% vs 36.7\u2009\u00b1\u200915%; <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001), lower CPR (39.8\u2009\u00b1\u20094% vs 43.4\u2009\u00b1\u20094%; <jats:italic>p<\/jats:italic>\u2009=\u20090.02) and lower LBR (33.9\u2009\u00b1\u20093.5% vs 37.9\u2009\u00b1\u20093.5%; <jats:italic>p<\/jats:italic>\u00a0&lt;\u20090.05). PGT rates were not significantly different. ICSI use in non-mandated states correlated with MF rates (r\u2009=\u20090.524, <jats:italic>p<\/jats:italic>\u2009=\u20090.03). A significant correlation between ICSI and CPR (<jats:italic>r<\/jats:italic>\u00a0=\u20090.8, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001) and LBR (<jats:italic>r<\/jats:italic>\u00a0=\u20090.7, <jats:italic>p<\/jats:italic>\u00a0&lt;\u20090.001) was noted in mandated states only. eSET rates were greater and twin rates were lower in mandated compared with non-mandated states.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>There was greater use of ICSI per clinic in non-mandated states, which correlated with an increased frequency of MF. In mandated states, lower ICSI rates per clinic were accompanied by a positive correlation with CPR and LBR, as well as a trend for greater eSET rates and lower twin rates, suggesting that state mandates for ART coverage may encourage more selective utilization of laboratory resources.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12958-020-00589-w","type":"journal-article","created":{"date-parts":[[2020,4,25]],"date-time":"2020-04-25T07:02:27Z","timestamp":1587798147000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Do state insurance mandates alter ICSI utilization?"],"prefix":"10.1186","volume":"18","author":[{"given":"Pavel","family":"Zagadailov","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David B.","family":"Seifer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"He","family":"Shan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shvetha M.","family":"Zarek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albert L.","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,4,25]]},"reference":[{"key":"589_CR1","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1097\/AOG.0000000000001733","volume":"128","author":"MP Provost","year":"2016","unstructured":"Provost MP, Thomas SM, Yeh JS, Hurd WW, Eaton JL. State insurance mandates and multiple birth rates after in vitro fertilization. Obstet Gynecol. 2016;128:1205\u201314.","journal-title":"Obstet Gynecol"},{"key":"589_CR2","unstructured":"Ill. Rev. Stat. ch. 215, \u00a7 5\/356m (1991, 1996). Available at: http:\/\/www.ilga.gov\/legislation\/ilcs\/. Accessed July 2018."},{"key":"589_CR3","unstructured":"Mass. Gen. Laws Ann. ch. 175, \u00a7 47H, ch. 176A, \u00a7 8K, ch. 176B, \u00a7 4J, ch. 176G, \u00a7 4 and 211 Code of Massachusetts Regulations 37.00 (1987, 2010). Available at: https:\/\/malegislature.gov\/Laws\/GeneralLaws\/. Accessed July 2018."},{"key":"589_CR4","unstructured":"New Hampshire Senate Bill 279. Available at: https:\/\/legiscan.com\/NH\/text\/SB279\/id\/1878418. Accessed Oct 2019."},{"key":"589_CR5","unstructured":"N.J. Stat. Ann. \u00a7 17:48-6x, \u00a7 17:48A-7w, \u00a7 17:48E-35.22 and \u00a7 17B:27\u201346.1x (2001). Available at: https:\/\/law.justia.com\/codes\/new-jersey\/. Accessed July 2018."},{"key":"589_CR6","unstructured":"R.I. Gen. Laws \u00a7 27\u201318-30, \u00a7 27\u201319-23, \u00a7 27\u201320-20 and \u00a7 27\u201341-33 (1989, 2007). Available at: http:\/\/webserver.rilin.state.ri.us\/Statutes\/. Accessed July 2018."},{"key":"589_CR7","unstructured":"A BillACT 920 OF 1991 - Arkansas General Assembly. Available at: ftp:\/\/www.arkleg.state.ar.us\/acts\/1991\/Public\/920.pdf. Accessed July 2018."},{"key":"589_CR8","unstructured":"Health Insurance Coverage for Infertility Treatment and Procedures \u2013 Conn. Gen. Stat. \u00a7 38a-509 and \u00a7 38a-536. Available at: http:\/\/www.ct.gov\/cid\/lib\/cid\/BulletinHC-104-InfertilityTreatmentandProcedures.pdf. Accessed July 2018."},{"key":"589_CR9","unstructured":"S.B. 502 S.D. 1, Hawaii State Legislature. Available at: https:\/\/www.capitol.hawaii.gov\/session2017\/bills\/SB502_SD1_.PDF. Accessed July 2018."},{"key":"589_CR10","unstructured":"Maryland 15\u2013810. In Vitro Fertilization Procedures. Available at: https:\/\/govt.westlaw.com\/mdc\/Document\/N877CC140341011E6A563D141CA0605C0?viewType=FullText&originationContext=documenttoc&transitionType=CategoryPageItem&contextData=(sc. Default)&bhcp=1. Accessed July 2018."},{"key":"589_CR11","unstructured":"An Act to Amend Title 18 of the Delaware Code Relating to Insurance Coverage for Obstetrical and Gynecological Services. Available at: https:\/\/legis.delaware.gov\/BillDetail?LegislationId=26219. Accessed Apr 2019."},{"key":"589_CR12","unstructured":"Senate Bill S3148A; Relates to insurance coverage of in vitro fertilization and other fertility preservation treatments. Available at: https:\/\/legislation.nysenate.gov\/pdf\/bills\/2017\/S3148A. Accessed Apr 2019."},{"issue":"6","key":"589_CR13","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1016\/j.fertnstert.2012.08.026","volume":"98","author":"S Pfeifer","year":"2012","unstructured":"Pfeifer S, Fritz M, Goldberg J, McClure RD, Lobo R, Thomas M, et al. Practice committees of the American Society for Reproductive Medicine and Society for Assisted Reproductive Technology. Intracytoplasmic sperm injection (ICSI) for non-male factor infertility: a committee opinion. Fertil Steril. 2012;98(6):1395\u20139.","journal-title":"Fertil Steril"},{"issue":"3","key":"589_CR14","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1056\/NEJMsa070707","volume":"357","author":"T Jain","year":"2007","unstructured":"Jain T, Gupta RS. Trends in the use of intracytoplasmic sperm injection in the United States. N Engl J Med. 2007;357(3):251\u20137.","journal-title":"N Engl J Med"},{"issue":"4","key":"589_CR15","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.fertnstert.2017.12.027","volume":"109","author":"AC Dieke","year":"2018","unstructured":"Dieke AC, Mehta A, Kissin DM, Nangia AK, Warner L, Boulet SL. Intracytoplasmic sperm injection use in states with and without insurance coverage mandates for infertility treatment, United States, 2000-2015. Fertil Steril. 2018;109(4):691\u20137.","journal-title":"Fertil Steril"},{"issue":"1","key":"589_CR16","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s12958-017-0263-4","volume":"15","author":"P Zagadailov","year":"2017","unstructured":"Zagadailov P, Hsu A, Seifer DB, Stern JE. Differences in utilization of intracytoplasmic sperm injection (ICSI) within human services (HHS) regions and metropolitan megaregions in the U.S. Reprod Biol Endocrinol. 2017;15(1):45.","journal-title":"Reprod Biol Endocrinol"},{"issue":"2","key":"589_CR17","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1097\/AOG.0000000000002730","volume":"132","author":"P Zagadailov","year":"2018","unstructured":"Zagadailov P, Hsu A, Stern JE, Seifer DB. Temporal differences in utilization of intracytoplasmic sperm injection among U.S. regions. Obstet Gynecol. 2018;132(2):310\u201320.","journal-title":"Obstet Gynecol"},{"key":"589_CR18","unstructured":"Centers for Disease Control and Prevention National ART Surveillance System, ART National Data. Available at: https:\/\/www.cdc.gov\/art\/nass\/. Accessed Dec 2017."},{"key":"589_CR19","unstructured":"Infertility Coverage and Age Discrimination, 2008-R-0106. Available at: https:\/\/www.cga.ct.gov\/2008\/rpt\/. Accessed July 2018."},{"key":"589_CR20","unstructured":"Massachusetts Infertility Benefits, 211 CMR 37.00. Available at: https:\/\/www.mass.gov\/files\/documents\/2016\/07\/tz\/211-37.pdf. Accessed July 2018."},{"issue":"1","key":"589_CR21","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1086\/341096","volume":"71","author":"GF Cox","year":"2002","unstructured":"Cox GF, B\u00fcrger J, Lip V, et al. Intracytoplasmic sperm injection may increase the risk of imprinting defects. Am J Hum Genet. 2002;71(1):162\u20134.","journal-title":"Am J Hum Genet"},{"issue":"5 Suppl","key":"589_CR22","first-page":"S182","volume":"90","author":"Practice Committee of the American Society for Reproductive Medicine, Practice Committee of the Society for Assisted Reproductive Technology","year":"2008","unstructured":"Practice Committee of the American Society for Reproductive Medicine, Practice Committee of the Society for Assisted Reproductive Technology. Genetic considerations related to intracytoplasmic sperm injection (ICSI). Fertil Steril. 2008;90(5 Suppl):S182\u20134.","journal-title":"Fertil Steril"},{"issue":"6","key":"589_CR23","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1016\/j.fertnstert.2012.02.053","volume":"97","author":"J Wen","year":"2012","unstructured":"Wen J, Jiang J, Ding C, et al. Birth defects in children conceived by in vitro fertilization and intracytoplasmic sperm injection: a meta-analysis. Fertil Steril. 2012;97(6):1331\u20137.","journal-title":"Fertil Steril"},{"issue":"9","key":"589_CR24","doi-asserted-by":"publisher","first-page":"2318","DOI":"10.1093\/humrep\/det278","volume":"28","author":"AP Ferraretti","year":"2013","unstructured":"Ferraretti AP, Goossens V, Kupka M, et al. Assisted reproductive technology in Europe, 2009: results generated from European registers by ESHRE. Hum Reprod. 2013;28(9):2318\u201331.","journal-title":"Hum Reprod"}],"container-title":["Reproductive Biology and Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12958-020-00589-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12958-020-00589-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12958-020-00589-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,24]],"date-time":"2021-04-24T23:33:00Z","timestamp":1619307180000},"score":1,"resource":{"primary":{"URL":"https:\/\/rbej.biomedcentral.com\/articles\/10.1186\/s12958-020-00589-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,25]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["589"],"URL":"https:\/\/doi.org\/10.1186\/s12958-020-00589-w","relation":{},"ISSN":["1477-7827"],"issn-type":[{"value":"1477-7827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,25]]},"assertion":[{"value":"22 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study qualified as \u201cnot human subject research\u201d by the MU Human Subjects Research Protections Program\/IRB at the University of Missouri.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"33"}}